Sobrevida de pacientes con cáncer de mama Her2 positivo tratadas en el Hospital de Solca Loja
Breast cancer HER2 positive (BRCA HER2 +) represents 20 to 30% of breast cancers, until before biological therapies was the most aggressive, with a 5-year survival of 74%. This is why arises the need for the current research whose main objective was to determine the 5-year survival in patients with...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | bachelorThesis |
| Kieli: | spa |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | http://dspace.unl.edu.ec/jspui/handle/123456789/22031 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Lisää tagi